Navigation Links
Michigan Catholic Conference Responds to Formation of Embryonic Stem Cell Research Ballot Committee
Date:10/11/2007

Poll: 77% Oppose Proposal to Kill Human Embryos for Research

LANSING, Mich., Oct. 11 /PRNewswire-USNewswire/ -- Michigan Catholic Conference President and Chief Executive Officer Sister Monica Kostielney, R.S.M., made the following statement today regarding the formation of the ballot question committee "Stem Cell Research BQC":

"In order to protect human life at its most vulnerable stage, any proposal, legislative or ballot related, that seeks to clone and/or kill human embryos in this state must be defeated. According to a statewide Public Opinion Strategies poll, 77 percent of Michigan residents oppose 'a proposal that would allow the killing of human embryos and using their stem cells for research.' Human life is not a commodity that can be created and killed in an effort to generate profits and patents. Michigan Catholic Conference will continue to advocate for ethical and proven adult stem cell research that is currently helping to provide treatments, even cures, for over 70 different diseases and chronic ailments."

On October 1 the Michigan Catholic Conference launched a massive statewide internal education program that sought to communicate the differences between adult and embryonic stem cell research and to convey the Church's support for adult stem cell research. The education program was unprecedented in the Conference's history and called for over 500,000 Catholic homes to learn more about the facts of stem cell research as it relates to the Church's obligation to help the sick while protecting human life. Nearly 800 parishes also received educational information from the Conference and were encouraged to address the issue of stem cell research during Respect Life Sunday, October 7.

Michigan Catholic Conference is the official public policy voice of the Catholic Church in this state.


'/>"/>
SOURCE Michigan Catholic Conference
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Venture Investors to open Michigan office
2. University of Michigan plans major stem cell research center
3. CPM contributes marketing program to Michigan hospital
4. For Now, Michigan Can Celebrate $150 Million Entrepreneurial VC Fund
5. Michigan Growth Capital Symposium includes Wisconsin Tech Companies
6. Digital Healthcare Conference 2007: Mounting obstacles for health IT
7. Biomedical engineering conference invites manufacturers
8. Conference to address small town development
9. Wisconsin to host SBIR Conference
10. Gaming conference explores interactive media in learning
11. Digital Healthcare Conference starts on a realistic note
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... ... Food and Drug Administration (FDA) inspection at our Dilworth, MN site. The inspection ... issued. This inspection was conducted as part of a routine Bioresearch Monitoring Program ...
(Date:8/15/2017)... After spending the past two years building a state-of-the-art technology which ... offers this platform to healthcare stakeholders (hospitals, foundations, biopharma companies etc.) ... collection vis a vis their members, under their own brand. Three ... offer. ... ...
(Date:8/15/2017)... ... August 15, 2017 , ... Pittcon is ... for analytical and scientific instruments. This year’s symposium, organized by the Pittcon 2018 ... Spectrometry for Bioanalytical Applications.” This dynamic presentation will discuss novel ionization processes, high ...
(Date:8/15/2017)... ... August 15, 2017 , ... The Conference Forum ... 360° (IO360°) programming through a series of upcoming panels and events. The partnership culminates ... at The Roosevelt Hotel in New York City. , “With our experience in producing ...
Breaking Biology Technology:
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/28/2017)... 28, 2017 The report "Video ... Monitors, Servers, Storage Devices), Software (Video Analytics, VMS), and ... Global Forecast to 2022", published by MarketsandMarkets, the market ... is projected to reach USD 75.64 Billion by 2022, ... The base year considered for the study is 2016 ...
Breaking Biology News(10 mins):